| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 1 | 1 | — | — | 1 | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 0.41 |
—
—
—
|
| 2025 | 0.40 |
—
—
—
—
|
| 2024 | 0.40 |
—
—
—
—
|
| 2023 | 0.40 |
—
—
—
—
|
| 2022 | 0.40 |
—
—
—
—
|
| 2021 | 0.40 |
—
—
—
—
|
| 2020 | 0.40 |
—
—
—
—
|
| 2019 | 0.40 |
—
—
—
—
|
| 2018 | 0.40 |
—
—
—
—
|
| 2017 | 0.40 |
—
—
—
—
|
| 2016 | 0.40 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 483.30 | 1,228.40 | 186.50 | 112.00 |
| Receivables | 214.40 | 239.70 | 442.90 | 443.00 |
| Inventory | 238.90 | 233.10 | 643.70 | 700.00 |
| Other | 163.60 | 162.10 | 310.00 | 359.00 |
| 1,100.20 | 1,863.30 | 1,583.10 | 1,614.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 134.60 | 131.00 | 261.90 | 300.00 |
| ST’ Debt | — | — | 411.90 | 9.00 |
| Other | 118.10 | 155.10 | 260.90 | 276.00 |
| 484.40 | 535.50 | 1,622.20 | 1,303.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 936.00 | 981.00 | — | — |
—
|
| ’25 | 854.00 | 935.00 | 1,001.30 | 1,007.90 |
3,798.20
|
| ’24 | 392.30 | 402.30 | 453.80 | 467.60 |
1,716.00
|
| ’23 | 388.50 | 427.70 | 403.60 | 444.60 |
1,664.40
|
| ’22 | 469.20 | 394.00 | 398.80 | 328.30 |
1,590.30
|
| ’21 | 417.80 | 475.50 | 477.40 | 30.10 |
1,400.80
|
| ’20 | 457.70 | 411.50 | 419.20 | 439.40 |
1,727.80
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 119.00 | 102.00 | — | — |
—
|
| ’25 | 34.00 | 103.00 | 87.30 | 117.40 |
341.70
|
| ’24 | 10.40 | 21.60 | 71.90 | 128.70 |
232.60
|
| ’23 | 11.40 | 51.20 | 33.00 | (21.40) |
74.20
|
| ’22 | 39.10 | 35.90 | 12.00 | 48.20 |
135.20
|
| ’21 | 85.70 | 44.60 | 33.00 | 11.60 |
174.90
|
| ’20 | 13.80 | 87.20 | 60.10 | 90.90 |
252.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 100.00 | 79.00 | — | — |
—
|
| ’25 | 15.00 | 88.00 | 56.10 | 85.60 |
244.70
|
| ’24 | 0.40 | 11.50 | 65.00 | 119.20 |
196.10
|
| ’23 | (4.80) | 32.60 | 22.80 | (29.40) |
21.20
|
| ’22 | 12.50 | 20.40 | (8.30) | 27.10 |
51.70
|
| ’21 | 77.40 | 34.30 | 19.70 | (2.50) |
128.90
|
| ’20 | 5.40 | 81.10 | 53.10 | 79.60 |
219.20
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.86 | 0.54 | — | — |
—
|
| ’25 | (3.35) | 0.07 | 1.26 | 1.01 |
(0.98)
|
| ’24 | 0.71 | 0.95 | 1.21 | (0.22) |
2.65
|
| ’23 | 0.80 | 0.97 | 14.54 | 2.52 |
18.13
|
| ’22 | 0.80 | 1.04 | 1.07 | 1.17 |
4.07
|
| ’21 | 0.84 | 0.95 | 0.91 | 0.99 |
3.69
|
| ’20 | 0.90 | 1.01 | 0.54 | 0.94 |
3.39
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 81.59 | 90.28 | 82.64 | 90.08 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 163.28 | 125.88 | 132.69 | 157.22 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,200 | 5,100 | 12,200 | 11,500 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.22 | 0.33 | 0.14 | 0.33 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,590.30 | 1,664.40 | 1,716.00 | 3,798.20 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.29% | 35.19% | 36.51% | 35.14% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 120.00 | 153.10 | 95.40 | (62.40) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.55% | 9.20% | 5.56% | (1.64%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 137.40 | 582.60 | 85.40 | (50.50) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 76.20 | 91.30 | 89.40 | 266.20 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 49.70 | 52.01 | 53.63 | 73.04 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡ | 4.08 | 18.21 | 2.67 | (0.98) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.23 | 2.32 | 7.27 | 6.57 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.61) | (1.66) | (1.14) | (1.87) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 1.62 | 0.66 | 6.13 | 4.71 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.29 | 46.53 | 48.26 | 85.84 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 32.00 | 32.00 | 32.00 | 52.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.66 | 5.11 | 47.60 | 0.00 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.87 | 1.86 | 2.37 | 2.06 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.28 | 2.08 | 2.63 | 1.76 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.43 | 1.96 | 2.38 | 2.51 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 74.90 | 153.62 | 20.87 | 38.95 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 135.20 | 74.20 | 232.60 | 341.70 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (83.50) | (53.00) | (36.50) | (97.00) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 51.70 | 21.20 | 196.10 | 244.70 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 302.50 | 615.80 | 1,327.80 | (39.10) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 977.90 | 646.40 | 1,252.10 | 1,881.90 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 906.20 | 163.10 | 23.70 | 1,695.40 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 905.40 | 1,488.90 | 1,544.20 | 4,463.80 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.75% | 21.77% | 2.79% | (0.87%) | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.57% | 6.23% | 4.72% | 1.92% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.60% | 48.67% | 5.63% | (1.68%) | — | — | — |
ROE
|
JBT Marel Corporation (JBTM), a global powerhouse in food processing and automation, has weathered cyclical demand swings, COVID disruptions, and a game-changing 2024 merger with Marel hf, doubling its addressable markets in protein and seafood. Revenue grew modestly at 3.4% CAGR from $1.35 billion in 2016 to $1.66 billion in 2023, but analysts forecast a explosive 119% surge to $3.76 billion in 2025 from synergies, with gross margins expanding from 28% to 36.5% amid pricing power and efficiencies. Stock volatility mirrors this—peaks at $177 in 2021, lows at $56 in 2020—now trading with modest 3-10% upside to targets but 39% downside risk tied to integration execution.
Strong cash generation underpins resilience, with FCF per share peaking at $25 in 2023 and net debt slashed 97% to near-zero, yielding an attractive 21x EV/FCF. ROE averaged 23% pre-merger but dipped to 5.6% in 2024 from dilution, eyeing 12% recovery alongside EPS jumping 126% to $4.83 in 2025. Yet, bearish insider selling ($4.5 million, no buys) and merger costs signal caution, contrasting bullish projections of 10%+ revenue CAGR through 2027.
Blending DCF and comps suggests 10% fair value upside, with 65% odds of 15%+ annualized returns if synergies deliver 38-40% margins and ESG-driven R&D pays off—though cyclical risks loom. Dive into the full analysis for Monte Carlo models, peer comps, and Q1 2026 catalysts.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.